HSP
Heat shock proteins (HSPs) are a family of highly conserved proteins that are expressed, either constitutively or regulated inductively, in response to a wide range of physiological and environmental insults, such as heat shock. According to molecular weight, mammalian HSPs are classified into four subfamilies, including HSP90 (90 kDa), HSP70 (70 kDa), HSP60 (60 kDa) and small HSPs (15 to 30 kDa), among which HSP90 and HSP70 are two of the most studied stress-inducible HSPs. HSP90 is a highly abundant chaperone protein characterized by containing three relevant domains, including the N-terminal domain, the charged middle linker region and the C-terminal dimerization domain; while HSP70 is an ATP-dependent chaperone protein characterized by containing two distinct functional domains, including a peptide binding domain (PBD) and the amino-terminal ATPase domain (ABD). Collectively HSPs play a fundamental role in maintaining the stability of other cellular proteins.
Products for HSP
- Cat.No. Product Name Information
-
GC63796
116-9e
MAL2-11B
116-9e (MAL2-11B) is a Hsp70 co-chaperone DNAJA1 inhibitor.
-
GC41955
17-DMAG
Alvespimycin, KOS1022, NSC 707545
17-DMAG (17-DMAG) is a potent inhibitor of Hsp90, binding to Hsp90 with an EC50 of 62 ± 29 nM.
-
GC13044
17-DMAG (Alvespimycin) HCl
17-DMAG (Alvespimycin) HCl is an effective inhibitor of Hsp90, with an IC50 value of 62nM.
-
GC65035
Apatorsen
OGX-427
Apatorsen?is?an?antisense?oligonucleotide?designed?to?bind?to?Hsp27?mRNA,?resulting?in?the?inhibition of?the?production?of?Hsp27?protein.
-
GC14411
Apoptozole
Apoptosis Activator VII
Apoptozole is a small inhibitor targets HSC70 and HSP72, with the KD values of 210nM and 140nM, respectively.
-
GC31103
Arimoclomol maleate (BRX-220)
BRX-220
Arimoclomol maleate (BRX-220) (BRX-220) is a co-inducer of heat shock proteins (HSP).
-
GC68703
AT-533
AT-533 is an effective inhibitor of Hsp90 and HSV. It inhibits tumor growth and angiogenesis by blocking the HIF-1α/VEGF/VEGFR-2 signaling pathway. AT-533 also inhibits downstream pathway activation, including Akt/mTOR/p70S6K, Erk1/2, and FAK. AT-533 suppresses tube formation, cell migration, and invasion in human umbilical vein endothelial cells (HUVEC).
-
GC13414
AT13387
AT-13387,Onalespib
AT13387 is a small-molecule, non-ansamycin HSP90 (heat shock protein 90) inhibitor that acts by targeting the AKT and ERK signaling pathways.
-
GC72078
Azadiradione
Azadiradione is a bioactive limonoid found in Azadirachta indica.
-
GC32620
Bimoclomol
Bimoclomol is a heat shock protein (HSP) coinducer, used for treatment of cardiovascular diseases.
-
GC65318
BOLD-100
NKP-1339 free base; IT-139 free base; KP-1339 free base
BOLD-100 is a ruthenium-based anticancer agent.
-
GC10223
CCT018159
inhibitor of the ATPase activity of Hsp90
-
GC19094
CCT251236
CCT251236 is an orally available pirin ligand from a heat shock transcription factor 1 (hsf1) phenotypic screen with an IC50 of 19 nM for inhibition of HSF1-mediated HSP72 induction.
-
GC17822
CH5138303
Hsp90 inhibitor, orally available
-
GC34539
Col003
Col003 is a selective and potent inhibitor of?Hsp47 and competitively binds to the collagen binding site on Hsp47 (IC50=1.8 μM).
-
GC35757
Cucurbitacin D
(+)-Cucurbitacin D, Elatericin A, NSC 308606, NSC 521776
Cucurbitacin D is an active component in Cucurbita texana, disrupts interactions between Hsp90 and two co-chaperones, Cdc37 and p23. Cucurbitacin D prevents Hsp90 client (Her2, Raf, Cdk6, pAkt) maturation without induction of the heat shock response. Anti-cancer activity.
-
GC19121
Debio 0932
CUDC-305
Debio 0932 is an orally active HSP90 inhibitor, with IC50s of 100 and 103 nM for HSP90α and HSP90β, respectively.
-
GC38223
Dihydroberberine
Dihydroberberine is a potent haematopoietic prostaglandin D2 synthase (H-PGDS), with an IC50 value of 3.7µM.
-
GC32965
Ethoxyquin
NSC 6795
An antioxidant used in animal feed
-
GC43649
Falcarinol
Falcarinol is a naturally derived, orally active Hsp90 inhibitor.
-
GC32008
Feretoside
Feretoside, a phenolic compound extracted from the barks of E.
-
GC33030
Gamitrinib TPP
Gamitrinib TPP is a Gamitrinib (GA) mitochondrial matrix inhibitor. Gamitrinib TPP is a mitochondrial-targeted HSP90 inhibitor with anticancer activity used to chemically interfere with mitochondrial protein folding and induce mitophagy.
-
GC64795
Geldanamycin-FITC
Geldanamycin-FITC, a Geldanamycin fluorescent probe, can be used in a fluorescence polarization assay for HSP90 inhibitors.
-
GC73388
GRP78-IN-3
GRP78-IN-3 (Compound 8) is a selective Grp78 (HSPA5) inhibitor with an IC50 of 0.59 μM.
-
GC64988
Grp94 Inhibitor-1
Grp94 Inhibitor-1 is a potent, selective Grp94 inhibitor with an IC50 value of 2 nM, and over 1000-fold selectivity to Grp94 against Hsp90α.
-
GC19188
HA15
HA15 is a molecule that specifically targets BiP/GRP78/HSPA5, binding to and inhibiting its ATPase activity, which leads to the dissociation of BiP from PERK, IRE1α, and ATF6, thereby triggering endoplasmic reticulum stress.
-
GC72637
Hexadecanoate-13C16 potassium
Hexadecanoate-13C16 (potassium) is the 13C-labeled Hexadecanoate sodium.
-
GC32437
HSF1A
HSF1A is an activator of Heat Shock Transcription Factor 1 (HSF1).
-
GC38503
HSP27 inhibitor J2
J2
HSP27 inhibitor J2 (J2) is an inhibitor of HSP27, which significantly induces abnormal HSP27 dimer formation and inhibits HSP27 macropolymer production.
-
GC32869
HSP70-IN-1
HSP70-IN-1 is a heat shock protein (HSP) inhibitor; inhibits the growth of Kasumi-1 cells with an IC50 of 2.3 μM.
-
GC68450
Hsp90-IN-17 hydrochloride
-
GC73701
HSP90-IN-27
HSP90-IN-27 (compound 19) is an HSP90 inhibitor.
-
GC11973
HSP990 (NVP-HSP990)
NVP-HSP990
HSP990 (NVP-HSP990) is a potent and selective Hsp90 inhibitor, with IC50 values of 0.6, 0.8, and 8.5 nM for Hsp90α, Hsp90β, and Grp94, respectively.
-
GC73962
iHSP110-33
iHSP110-33 is an inhibitor for heat shock protein 110 (HSP110).
-
GC69312
JG-231
JG-231 is a JG-98 analogue with anti-cancer properties. It can inhibit the interaction between Hsp70-BAG3. JG-231 has an inhibitory effect on the MDA-MB-231 xenograft model of triple-negative breast cancer (TNBC).
-
GC34634
JG-98
JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor, which binds tightly to a conserved site on Hsp70 and disrupts the Hsp70-Bag3 interaction. JG-98 shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages.
-
GC11930
KNK437
Hsp Inhibitor I, KNK 437
stress-induced HSP synthesis inhibitor
-
GC64370
Kongensin A
Kongensin A is a natural product isolated from Croton kongensis.
-
GC19215
KRIBB11
KRIBB11 is a potent heat shock factor 1 (HSF1) inhibitor, with an IC50 value of 1.2µM.
-
GC31118
KU-32
KU-32 is a novel, novobiocin-based Hsp90 inhibitor that can protect against neuronal cell death.
-
GC69426
MAL3-101
MAL3-101 is an effective inhibitor of heat shock protein 70 (HSP70) conformational changes. MAL3-101 inhibits HSP70 ATPase activity by blocking the interaction of Hsp40 molecular chaperones. MAL3-101 can be used for research on invasive bladder cancer.
-
GC12301
Mizoribine
NSC 289637
DNA/RNA synthesis inhibitor
-
GC17751
MKT 077
FJ-776
mortalin-2 (mot-2) inhibitor
-
GC64714
NCT-58
NCT-58 is a potent inhibitor of C-terminal HSP90. NCT-58 does not induce the heat shock response (HSR) due to its targeting of the C-terminal region and elicits anti-tumor activity via the simultaneous downregulation of HER family members as well as inhibition of Akt phosphorylation. NCT-58 kills Trastuzumab-resistant breast cancer stem-like cells. NCT-58 induces apoptosis in HER2-positive breast cancer cells.
-
GC13105
NMS-E973
Hsp90 inhibitor,potent and selective
-
GC64655
NXP800
CCT361814
NXP800 (CCT361814) is a potent heat shock factor 1 (HSF1) inhibitor. NXP800 has?the?potential?for?cancer research.
-
GC36834
p5 Ligand for Dnak and DnaJ
p5 Ligand for Dnak and DnaJ is a nonapeptide, which corresponds to the main binding site for the 23-residue part of the presequence of mitochondrial aspartate aminotransferase.
-
GC71863
Palmitic acid-13C16 sodium
Palmitic acid-13C16 (sodium) is the 13C-labeled Palmitic acid sodium.
-
GC71865
Palmitic acid-13C2
Palmitic acid-13C2 is the 13C-labeled Palmitic acid.
-
GC63852
Palmitic acid-d3
-
GC67916
Palmitic acid-d4
-
GC11912
PF-04929113 (SNX-5422)
SNX-5422
Hsp90 inhibitor,potent and selective
-
GC69777
PU-H54
PU-H54 is a selective inhibitor of Grp94, which can be used for the study of breast cancer. The Hsp90 chaperone family includes Hsp90α, Hsp90β, Grp94 and Trap-1, which play important roles in malignant tumors.
-
GC37040
PU-H71 hydrochloride
-
GC13307
PU-WS13
PU-WS13 is a purine scaffold-based Grp94-specific heat shock protein 90 (Hsp90) inhibitor.
-
GC19548
Rocaglamide
Rocaglamide A; Roc-A
Rocaglamide is a potent NF-κB activation inhibitor.
-
GC71198
SEW84
SEW84 is an inhibitor of the Aha1stimulated Hsp90 (ASH) ATPase activity.
-
GC64685
SNX-0723
SNX-0723 is a potent Hsp90 Inhibitor with anti-Plasmodium activity.
-
GC33047
SNX-5422 Mesylate (PF-04929113 (Mesylate))
-
GC19521
Sodium Palmitate
Hexadecanoic acid sodium salt, Palmitic acid sodium salt
Sodium palmitate is a common saturated fatty acid produced during the process of fatty acid synthesis.
-
GC17901
Tamoxifen
Tamoxifen(TAM) serves as a selective estrogen receptor regulator (SERM), inhibiting estrogen's effects in breast cells while potentially stimulating estrogen activity in cells found in different tissues.
-
GC11669
Tamoxifen Citrate
ICI 46474, Istubal, Kessar, Noltam, Nolvadex, TMX, Valodex, Zemide
Antiestrogen drug
-
GC33286
TAS-116
TAS-116
TAS-116 (TAS-116) is an oral bioavailable, ATP-competitive, highly specific HSP90α/HSP90β inhibitor (Kis of 34.7 nM and 21.3 nM, respectively) without inhibiting other HSP90 family proteins such as GRP94. TAS-116 demonstrates less ocular toxicity.
-
GC33663
Teprenone (Geranylgeranylacetone)
Teprenone
Teprenone (Geranylgeranylacetone) is an anti-ulcer drug, and works as an inducer of heat shock proteins (HSPs).
-
GC10481
TRC 051384
HSP70 inducer
-
GC13556
VER-49009
CCT 129397
HSP90 inhibitor, potent and selective
-
GC10501
VER-50589
HSP90 inhibitor, potent
-
GC66059
YZ129
YZ129 is an inhibitor of the HSP90-calcineurin-NFAT pathway against glioblastoma, directly binding to heat shock protein 90 (HSP90) with an IC50 of 820 nM on NFAT nuclear translocation. YZ129-induced GBM cell-cycle arrest at the G2/M phase promotes apoptosis and inhibited tumor cell proliferation and migration.
-
GC72823
Zelavespib formic
PU-H71 formic
Zelavespib formic (PU-H71 formic) is a potent Hsp90 inhibitor with an IC50 value of 51 nM for Hsp90 in MDA-MB-468 cells.
-
GC72822
Zelavespib hydrochloride
PU-H71 hydrochloride
Zelavespib (PU-H71) drochloride is a potent Hsp90 inhibitor, with an IC50 of 51 nM in MDA-MB-468 cells.